|
1
|
American Cancer Society, . Global Cancer
Facts & Figures (4th Edition). American Cancer Society.
Atlanta, GA: 2018.
|
|
2
|
American Cancer Society, . Breast Cancer
Facts & Figures 2017–2018. American Cancer Society. Atlanta,
GA: 2017.
|
|
3
|
Kenny PA, Lee GY, Myers CA, Neve RM,
Semeiks JR, Spellman PT, Lorenz K, Lee EH, Barcellos-Hoff MH,
Petersen OW, et al: The morphologies of breast cancer cell lines in
three-dimensional assays correlate with their profiles of gene
expression. Mol Oncol. 1:84–96. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sung SY, Hsieh CL, Wu D, Chung LW and
Johnstone PA: Tumor microenvironment promotes cancer progression,
metastasis and therapeutic resistance. Curr Probl Cancer.
31:36–100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao Y, Liu S, Huang J, Guo W, Chen J,
Zhang L, Zhao B, Peng J, Wang A, Wang Y, et al: The ECM-cell
interaction of cartilage extracellular matrix on chondrocytes.
Biomed Res Int. 2014:6484592014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Debrand E, El Jai Y, Spence L, Bate N,
Praekelt U, Pritchard CA, Monkley SJ and Critchley DR: Talin 2 is a
large and complex gene encoding multiple transcripts and protein
isoforms. FEBS J. 276:1610–1628. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Senetar MA, Moncman CL and McCann RO:
Talin2 is induced during striated muscle differentiation and is
targeted to stable adhesion complexes in mature muscle. Cell Motil
Cytoskeleton. 64:157–173. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsujioka M, Yoshida K and Inouye K: Talin
B is required for force transmission in morphogenesis of
Dictyostelium. EMBO J. 23:2216–2225. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang C, Rajfur Z, Yousefi N, Chen Z,
Jacobson K and Ginsberg MH: Talin phosphorylation by Cdk5 regulates
Smurf1-mediated talin head ubiquitylation and cell migration. Nat
Cell Biol. 11:624–630. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jin JK, Tien PC, Cheng CJ, Song JH, Huang
C, Lin SH and Gallick GE: Talin1 phosphorylation activates β1
integrins: A novel mechanism to promote prostate cancer bone
metastasis. Oncogene. 34:1811–1821. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sakamoto S, McCann RO, Dhir R and
Kyprianou N: Talin1 promotes tumor invasion and metastasis via
focal adhesion signaling and anoikis resistance. Cancer Res.
70:1885–1895. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang KP, Dai W, Ren YH, Xu YC, Zhang SM
and Qian YB: Both Talin-1 and Talin-2 correlate with malignancy
potential of the human hepatocellular carcinoma MHCC-97 L cell. BMC
Cancer. 16:452016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang Y, Chen H, Ji L, Du J, Xie X, Li X
and Lou Y: Talin2 regulates breast cancer cell migration and
invasion by apoptosis. Oncol Lett. 16:285–293. 2018.PubMed/NCBI
|
|
14
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM classification of malignant tumours (7th edition). John
Wiley and Sons. 2009.
|
|
15
|
World Health Organization, . Tumours of
the Breast and Female Genital Organs. Oxford University Press.
2003.
|
|
16
|
Liu B, Pang B, Hou X, Fan H, Liang N,
Zheng S, Feng B, Liu W, Guo H, Xu S and Pang Q: Expression of
high-mobility group AT-hook protein 2 and its prognostic
significance in malignant gliomas. Hum Pathol. 45:1752–1758. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu Z, Li X, Sunkara M, Spearman H, Morris
AJ and Huang C: PIPKIγ regulates focal adhesion dynamics and colon
cancer cell invasion. PLoS One. 6:e247752011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Spano D and Zollo M: Tumor
microenvironment: A main actor in the metastasis process. Clin Exp
Metastasis. 29:381–395. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Swartz MA, Iida N, Roberts EW, Sangaletti
S, Wong MH, Yull FE, Coussens LM and DeClerck YA: Tumor
microenvironment complexity: Emerging roles in cancer therapy.
Cancer Res. 72:2473–2480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fais S, Venturi G and Gatenby B:
Microenvironmental acidosis in carcinogenesis and metastases: New
strategies in prevention and therapy. Cancer Metastasis Rev.
33:1095–1108. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Upadhyay M, Samal J, Kandpal M, Singh OV
and Vivekanandan P: The Warburg effect: Insights from the past
decade. Pharmacol Ther. 137:318–330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nozawa-Suzuki N, Nagasawa H, Ohnishi K and
Morishige K: The inhibitory effect of hypoxic cytotoxin on the
expansion of cancer stem cells in ovarian cancer. Biochem Biophys
Res Commun. 457:706–711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Macheda ML, Rogers S and Best JD:
Molecular and cellular regulation of glucose transporter (GLUT)
proteins in cancer. J Cell Physiol. 202:654–662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Icard P and Lincet H: A global view of the
biochemical pathways involved in the regulation of the metabolism
of cancer cells. Biochim Biophys Acta. 1826:423–433.
2012.PubMed/NCBI
|
|
27
|
Gaikwad SM and Ray P: Non-invasive imaging
of PI3K/Akt/mTOR signalling in cancer. Am J Nucl Med Mol Imaging.
2:418–431. 2012.PubMed/NCBI
|
|
28
|
Edinger AL and Thompson CB: Akt maintains
cell size and survival by increasing mTOR-dependent nutrient
uptake. Mol Biol Cell. 13:2276–2288. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Coddou C, Sandoval R, Castro P, Lazcano P,
Hevia MJ, Rokic M, Hall B, Terse A, Gonzalez-Billault C, Kulkarni
AB, et al: Cyclin-dependent kinase 5 modulates the P2X2a receptor
channel gating through phosphorylation of C-terminal threonine 372.
Pain. 158:2155–2168. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hixon ML, Paccagnella L, Millham R,
Perez-Olle R and Gualberto A: Development of inhibitors of the
IGF-IR/PI3K/Akt/mTOR pathway. Rev Recent Clin Trials. 5:189–208.
2010. View Article : Google Scholar : PubMed/NCBI
|
